MET Stock Recent News

MetLife (MET) launches 360Health in Nepal and 360Future in Korea to empower its clients to effectively manage their health conditions and enjoy a happy retirement life.

MetLife's stock (NYSE: MET) has lost 13% YTD as compared to the 18% increase in the S&P500 index over the same period.

Two major players in the insurance and financial management sector are currently showing indications of a trend shift, setting the stage for a significant breakout. The recent price movements and the formation of bullish technical patterns serve as a clear signal to investors and momentum traders.

MetLife's stock NYSE: MET has endured a rather forgettable year. Up to this point in the year, the stock has experienced a decline of nearly 14%, significantly lagging behind the broader market.

MetLife (MET) makes Empathy's bereavement care platform available to its customers so that families can better handle administrative hassles and get emotional support following the loss of a loved one.

There are as many as five trendlines working against the insurance stock.

MetLife's (MET) cost-curbing initiatives are likely to lower expenses, increase efficiency and boost profit levels.

My previous MetLife neutral/hold rating from May is affirmed, and I'm less bullish than the analyst consensus. Positives: dividend yield & stability, capital strength / solid scores from ratings agencies, share price presents buying range. Headwinds: high valuation vs. sector, disappointing YoY net earnings growth.

MetLife's (MET) asset management arm, MetLife Investment Management, ventures into single-family rental space with a new fund, securing capital commitments of $390 million.

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does MetLife (MET) have what it takes?